NASDAQ:LNAI
Lunai Bioworks Inc.
Lunai Bioworks Inc. reported net income of −$178.0M in fiscal 2025. The diluted share count rose 69.3%.Summary generated from Lunai Bioworks Inc.'s SEC filings. Latest annual report filed Sep 29, 2025.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)n/a
Revenue growthn/a
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating marginn/a
Net marginn/a
ROICn/a
Return on equity−321.8%
Debt / equityn/a
Free cash flown/a
FCF marginn/a
Share count change+69.3%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | n/a | n/a | n/a | n/a | n/a |
| Operating income | −23 | −116 | −39 | −82 | −189 |
| Net income | −27 | −113 | −40 | −88 | −178 |
| Free cash flow | −21 | −16 | −12 | −11 | n/a |
Recent filings
- 8-KOther events
Oct 9, 2026 - 8-KOther events
Jun 17, 2026 - 8-KOther events
Jun 16, 2026 - 8-KOther events
May 20, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 15, 2026 - 8-KResults of a shareholder vote
May 13, 2026 - 8-K/AAmended notice of delisting or listing-rule failure
May 11, 2026 - 8-KEntry into a material agreement
May 1, 2026